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FC-03
Cardiovascular safety in users of
different combined oral
contraceptives – Final results from
the INAS-SCORE study
Klaas Heinemanna, Christian Frankeb,
Sabine Moehnerb, Thai Do Minhb and
Juergen Dingerb
aBerlin Center for Epidemiology and Health Research (ZEG),
Berlin, Germany; bZEG Berlin, Berlin, Germany
Background: A new combined oral contraceptive (COC) with a
26-day regimen containing estradiol valerate (EV) and dienogest
(DNG), known as Qlaira (and Natazia in the US), was launched
in 2009. It was unknown whether this new regimen and com-
bination has an impact on the cardiovascular risk associated
with the use of COCs. The INAS-SCORE study was conducted to
investigate the cardiovascular long- and short-term safety of the
EV/DNG containing COC compared to established COCs.
Design/methods: The ‘International Active Surveillance Study –
Safety of Contraceptives: Role of Estrogens’ (INAS-SCORE) was
requested by the Medicines Evaluation Board as a post-author-
isation safety study. It was a large, prospective, controlled, non-
interventional, long-term cohort study with active surveillance
of the study participants. It was conducted in the US as well as
in Austria, France, Germany, Italy, UK, Poland and Sweden.
Women prescribed a new COC (either first-time user or
switcher) were recruited by a network of prescribing physicians.
Recruitment started in 2009 and was finished in 2012. Every 6
months during the first two years and yearly thereafter, the
woman was contacted and specifically asked about hormonal
contraceptive use and serious adverse events. All self-reported
clinical outcomes of interest were validated by healthcare pro-
fessionals. Main clinical outcomes of interest were venous
thromboembolism and arterial thromboembolism. The last
patient follow-up was finalissed in January 2017. All analyses
make allowance for confounding, using multivariate techniques
such as Cox regression models. As requested by the European
Medicinal Agency, final analyses are based on the European
data only.
Results: The final analysis was based on 112,638 women-years
(WY) of observation and 69,888 WY of OC exposure. Overall, 68
VTEs and 32 ATEs have occurred. For Qlaira (11 VTE), the VTE
incidence was 7.1/10,000 WY and for Other COCs (44 VTE) 8.1/
10,000 WY, including 9 VT in LNG-COC users (8.8/10,000 WY).
The crude HRs for Qlaira vs. Other COCs and Qlaira vs LNG-
COCs were 0.9 (95% CI: 0.4–1.7) and 0.8 (95% CI: 0.3–2.0),
respectively. Adjustment for age, BMI, duration of current OC
use and family history of VTE lead to HRs of 0.4 (95% CI:
0.2–0.9) and 0.4 (95% CI: 0.2–1.1), respectively. ATE incidences
were very low with 0.7 ATE/10,000 WY for Qlaira and 3.5 ATE/
10,000 WY for Other COCs. With regard to ATE, no results from
the standard model were available because the minimum num-
ber of events per cohort was not reached. As requested by the
FDA, a modified COX model was used with only duration of use
and exposure as time-dependent covariates. The adjusted haz-
ard ratios (HRadj) for DNG/EV vs. COCother and vs. LNG sub-
cohort were 0.1 (95% CI 0.0–0.6) and 0.1 (95% CI 0.0–1.2),
respectively.
Conclusions: The results do not suggest a higher VTE or ATE
risk of Qlaira users compared to users of Other COCs in a study
population that is representative of actual users.
Disclosure statement
This was a post-authorisation safety study (PASS), which was requested
by the European Medicines Agency (EMA). It was supervised by an
Independent Safety Monitoring and Advisory Board. The study was sup-
ported by an unconditional grant from Bayer AG.
FC-04
Research integrated with policy
makers: real-time health policy and
service improvements during ‘CART-
mifepristone implementation
research’, Canada
Wendy V. Normana, Sarah Munroa,
Courtney Devanea, Sheila Dunnb, Edith Guilbertc,
Marie-Soleil Wagnerd, Judith Soona, Regina Rennera,
Melissa Brookse, Dustin Costescuf,
Ashley Waddingtong, Janusz Kaczorowskih,
Cheryl Daviesi and Tamil Kendallj
aUniversity of British Columbia, Vancouver, Canada; bUniversity of
Toronto, Toronto, Canada; cInstitut national de sante publique du
Quebec, Quebec, Canada; dUniversite de Montreal, Montreal,
Canada; eDalhousie University, Halifax, Nova Scotia, Canada;
fMcMaster University, Hamilton, Ontario, Canada; gQueen’s
University at Kingston, Kingston, Ontario, Canada; hUniversite de
Montreal, Montreal, Canada; iBC Women’s Hospital & Health
Centre, Vancouver, Canada; jPerinatal Services BC, Vancouver,
Canada
Objective: Fewer than 300 physicians provided induced abor-
tions in Canada in 2012, and care was largely provided in surgi-
cal facilities in large southern cities. The January 2017
introduction of mifepristone has the potential to address this
geographic disparity. However, regulatory restrictions to distri-
bution, prescribing and dispensing present substantial barriers
to primary care providers, a crucial element for equitable abor-
tion access. Our objectives:
a. understand implementation facilitators/barriers for
mifepristone nationally;
b. assess impact of an online ‘Community of Practice’ clin-
ical support platform;
c. develop integrated knowledge translation (iKT) to
improve mifepristone related health policies, systems
and practice.
Methods: Our prospective mixed methods implementation
research met StaRI standards. Beginning January 2017, we
enrolled physicians, pharmacists and stakeholders. Quantitative
data included surveys based on Greenhalgh’s theory. Qualitative
data included open survey questions, semi-structured interviews
and Community of Practice interactions. Using iKT with a
diverse team of relevant decision makers, we aimed to detect
and mitigate health policy, system and service barriers to sup-
port effective primary care mifepristone implementation.
Results: As of October 2017, 283 physicians/369 pharmacists
completed surveys; we conducted 63 interviews, and 177 physi-
cians/165 pharmacists joined the Community of Practice.
Among physicians, 32% had never provided abortion before,
and 8% worked in communities with no prior abortion service.
Triangulation of findings identified barriers including: mandated
physician-only dispensing and pharmacist training, inadequate
drug subsidy and practitioner-payment mechanisms, and confu-
sion about changing regulations. Continuous iKT strategies
included knowledge brokering with evidence briefs, geo-maps
relating progressive policy to improved access, Community of
Practice member announcements, face-to-face meetings, and
regular correspondence with health policy, system, and service
decision makers. The Community of Practice effectively con-
nected prescribers with dispensing pharmacies; site members
used clinical decision support tools, exchange of case studies
and expert advice services. Over the first 10 months, leaders
from government, health system and professional organisations
increasingly requested evidence briefs and joined monthly team
meetings. Our iKT enabled nimble detection and timely removal
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of barriers, including the federal requirements for observed dos-
ing, practitioner training, practitioner registration, physician-only
prescribing and dispensing. Pharmacist dispensing directly to
women, and nurse-practitioner prescribing are now allowed in
Canada.
Conclusions: This study identified and mitigated health policy,
system and service barriers to mifepristone abortion access,
accelerating its implementation across Canada. The rapid uptake
of our study findings into practice and policy demonstrate the
impact of iKT on implementation/dissemination of new practi-
ces, and may facilitate increased access to equitable, safe, confi-
dential abortion care closer to home.
FC-05
The provision of free-of-charge LARC
methods and the risk of unintended
pregnancy – a register based cohort
study
Frida Gyllenberga, Anna Buta, Mika Gisslerb and
Oskari Heikinheimoa
aUniversity of Helsinki, Helsinki, Finland; bNational Institute of
Health and Welfare, Helsinki, Finland
Objective: To study the effect of a public free-of-charge LARC
programme as part of the primary healthcare services on the
risk of unintended pregnancy.
Design and methods: In this prospective cohort study, we
evaluate the risk of unintended pregnancy among women of
different contraceptive status. All women in the city of Vantaa,
Southern Finland, have been entitled to their first LARC method
free-of-charge at public family planning clinics since 2013. The
cohort consisted of all non-sterilised, non-pregnant women
aged 15–44 living in Vantaa during 2013–2014, and the out-
come was unintended pregnancy during 2013–2016. As infor-
mation on unintended pregnancy is scarce, we measured
induced abortions and the proportion of pregnancies ending in
abortion as proxies for unintended pregnancy. We compared
the following contraceptive statuses: (i) women entitled to a
free-of-charge LARC method, but not visiting a family planning
clinic, (ii) women entitled to a free-of-charge LARC method, vis-
iting a family planning clinic but chose a short-acting method,
(iii) women who obtained a LARC method at no-cost at a public
family planning clinic.
Results: During 2013–2014, there were 41,525 women entitled
to a LARC method that did not visit a public family planning
clinic. Of them, 8721 became pregnant (21.0%) and 1718
women had an abortion (19.6% of the pregnancies, 4.1% of all
women, incidence rate 11.9/1000 person years). Of the 8347
women who visited a public family planning clinic, 985 women
chose a LARC method free-of-charge and among these there
were 91 pregnancies (9.2%) and 11 abortions (12.1% of all preg-
nancies, 1.1% of all women, incidence rate 3.63/1000 person-
years). The corresponding numbers among the 7362 women
not choosing a LARC method were 1098 pregnancies (14.9%)
and 235 abortions (21.4% of all pregnancies, 3.2% of all
women). In our preliminary, unadjusted Poisson regression ana-
lysis of abortions among LARC-users vs. non-LARC-users, we
found that the relative risk for an induced abortion was 0.43
(95% CI¼ 0.21, 0.79, p¼.005).
Conclusions: The abortion rate among FPC visitors was twice as
high as in the general population. Initiation of a LARC method
was effective in reducing the pregnancy and abortion rate
among women choosing it. Women seeking counseling on
contraception are sexually active and at great risk of unintended
pregnancy. Providing the most effective reversible contraception
is an efficient means to meet the need of family planning.
FC-06
Factors influencing the sexual and
reproductive health of Muslim
women - a systematic review
Noura Alomaira, Samah Alageelb, Nathan Daviesa
and Julia Baileya
aUCL, London, United Kingdom; bKing’s College London, London,
United Kingdom
Background: In Islamic societies, issues related to sexual and
reproductive health (SRH) are rarely discussed and considered
to be sensitive subjects. As a result, poor SRH knowledge and
practices can be observed among the majority of Muslims in all
parts of the world.
Objectives:
 Explore factors affecting SRH among Muslim women;
 Explore barriers and facilitators to contraception and
family planning services;
 Explore barriers and facilitators to accessing SRH serv-
ices and advice;
 Explore barriers and facilitators to sexually transmitted
infections (STIs) prevention, diagnosis, and treatment.
Methods: A systematic review was conducted on seven elec-
tronic databases. Included were studies focusing on SRH of
Muslim women in reproductive age worldwide in three main
areas: contraception, access to SRH services and SITs. A narrative
synthesis approach was used to synthesise the data.
Results: Seventy-four studies were included, both qualitative
and quantitative. Barriers to contraception use among Muslim
included poor reproductive knowledge, insufficient knowledge
about contraception, misconceptions and negative attitudes.
Family and community appeared to have a significant impact
on women’s contraceptive use and access to SRH services.
Many women cited husbands’ refusal as the main barrier to
contraception use. Religious and cultural beliefs also acted as
barriers to contraception use and accessing SRH services. Fear
of stigmatisation among unmarried women prevented them
from seeking SRH services and advice when needed. Having
services labelled as public or general services instead of ‘repro-
ductive’ or ‘sexual’ was expressed by single women as a facilita-
tor to seeking SRH services. Poor knowledge about STIs
transmission, prevention and treatment was consistently
observed among Muslim women. In addition, negative attitudes
towards HIV infected individuals were found, these negative
attitudes were highly influenced by poor knowledge and
misconceptions.
Conclusion: The findings reveal that there are multiple levels of
factors that influence Muslim women’s SRH. Many women have
poor SRH knowledge, which in some cases acted as a barrier to
accessing contraception and other SRH services. Negative atti-
tudes towards contraception influenced women’s uptake and
use; these attitudes appeared to be affected by wider socio-cul-
tural and religious factors. SRH services were perceived to be
associated with sexual activity. As a result, unmarried women
faced greater difficulties accessing SRH services. Increasing
awareness would empower Muslim women to take charge of
their own reproductive health choices. Therefore, a culturally
and religiously sensitive SRH education is essential to improve
SRH knowledge and practices among Muslim women.
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